APA (7th ed.) Citation

X, X., D, L., X, S., K, Y., P, L., J, L., . . . B, Z. (2026). In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer's disease continuum. European journal of nuclear medicine and molecular imaging, 53(12), 7460. https://doi.org/10.1007/s00259-026-08067-y

Chicago Style (17th ed.) Citation

X, Xu, et al. "In Vivo Multimodal PET/MRI Imaging and Plasma Biomarkers Implicate Glymphatic Dysfunction Linking Neuroinflammation to Tau Pathology in the Early Alzheimer's Disease Continuum." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 12 (2026): 7460. https://doi.org/10.1007/s00259-026-08067-y.

MLA (9th ed.) Citation

X, Xu, et al. "In Vivo Multimodal PET/MRI Imaging and Plasma Biomarkers Implicate Glymphatic Dysfunction Linking Neuroinflammation to Tau Pathology in the Early Alzheimer's Disease Continuum." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 12, 2026, p. 7460, https://doi.org/10.1007/s00259-026-08067-y.